FDA Approval Activities for this Drug…

Pergolide Mesylate Tablets, 0.05, 0.25 & 1 mg (base), Ivax ANDA 76-094 9/4/03 Pergolide Mesylate Tablets, 0.05, 0.25 & 1 mg (base), Ivax ANDA 76-094 4/24/03 Pergolide Mesylate Tablets, 0.05 mg (base), 0.25 mg (base), & 1 mg (base), Teva USA ANDA 76-061 Permax (pergolide mesylate) Tablets, Eli Lilly and Company NDA 19-385/S30, S31 & S35 10/2/03 10/9/03 10/10/03 Permax (pergolide mesylate) Tablets, 0.05, 0.25 and 1.0 mg Eli Lilly and Company NDA 19-385/S-028 8/29/02 9/11/02 Permax (pergolide mesylate) Tablets, 0.05, 0.25 and 1.0 mg Eli Lilly and Company NDA 19-385/S-028, S-030 PERGOLIDE MESYLATE Tablet; 0.05MG BASE PERGOLIDE MESYLATE Ivax 076094 PERGOLIDE MESYLATE Tablet; 0.25MG BASE PERGOLIDE MESYLATE Ivax 076094 PERGOLIDE MESYLATE Tablet; 1MG BASE PERGOLIDE MESYLATE Ivax 019385 PERGOLIDE MESYLATE Tablet; 0.05MG BASE PERMAX LILLY 019385 PERGOLIDE MESYLATE Tablet; 0.25MG BASE PERMAX LILLY 019385 PERGOLIDE MESYLATE Tablet; 1MG BASE PERMAX LILLY 076061 PERGOLIDE MESYLATE Tablet; 0.05MG BASE PERGOLIDE MESYLATE Teva 076061 PERGOLIDE MESYLATE Tablet; 0.25MG BASE PERGOLIDE MESYLATE Teva 076061 PERGOLIDE MESYLATE Tablet; 1MG BASE PERGOLIDE MESYLATE Teva

For the latest approval information, please see the main page.